Evidence mapPaperPMID 41904803Full record

SynthesisJournal of the American Heart Association2026

Comparison of Intravascular Imaging-, Physiology-, or Angiography-Guided Approaches for Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.

Tetsuya Saito, Tadao Aikawa, Yuko Kiyohara, Hiroki A Ueyama, Hisato Takagi, Jose Wiley, Eric A Secemsky, Robert W Yeh, Roger Laham, Akiko Maehara and 1 more

Abstract readSystematic ReviewNetwork Meta-AnalysisComparative Study
In one paragraph

Synthesis in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tetsuya SaitoDepartment of Cardiology Edogawa Hospital Tokyo Japan.ORCID 0000-0001-5356-9477
Tadao AikawaDepartment of Cardiovascular Biology and Medicine Juntendo University Graduate School of Medicine Tokyo Japan.ORCID 0000-0002-1786-0176
Yuko KiyoharaDepartment of Medicine, Icahn School of Medicine at Mount Sinai Mount Sinai Morningside and West New York, NY USA.ORCID 0000-0001-7868-2310
Hiroki A UeyamaDivision of Cardiology Emory University School of Medicine Atlanta Georgia USA.ORCID 0000-0003-4812-7193
Hisato TakagiDivision of Cardiovascular Surgery Shizuoka Medical Center Shizuoka Japan.ORCID 0000-0002-5594-8072
Jose WileySection of Cardiology, Department of Medicine Tulane University School of Medicine New Orleans LA USA.ORCID 0000-0002-9940-0367
Eric A SecemskyDivision of Cardiology Beth Israel Deaconess Medical Center Boston MA USA.ORCID 0000-0003-3861-3163
Robert W YehDivision of Cardiology Beth Israel Deaconess Medical Center Boston MA USA.ORCID 0000-0002-0564-4468
Roger LahamDivision of Cardiology Beth Israel Deaconess Medical Center Boston MA USA.ORCID 0000-0001-8336-3779
Akiko MaeharaCenter for Interventional Cardiovascular Care Columbia University New York, NY USA.ORCID 0000-0002-1910-8447
Toshiki KunoDivision of Cardiology Beth Israel Deaconess Medical Center Boston MA USA.ORCID 0000-0002-2487-8366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite current guidelines recommending physiology- and intravascular imaging-guided percutaneous coronary intervention (PCI) in specific lesion subsets, angiography-guided PCI remains common in practice. The comparative effectiveness of these strategies remains uncertain. We aimed to compare clinical outcomes of PCI guided by intravascular imaging or physiological assessment versus conventional angiography.

methodsWe conducted a systematic review and network meta-analysis of randomized controlled trials, searching PubMed and EMBASE up to May 31, 2025. Eligible studies compared at least 2 of the following 6 guidance modalities in PCI: angiography, intravascular ultrasound (IVUS), optical coherence tomography/optical frequency domain imaging, fractional flow reserve, angiography-derived fractional flow reserve, and instantaneous wave-free ratio. The primary outcome was trial-defined major adverse cardiovascular events (MACEs). Hazard ratios (HRs) with 95% CIs were pooled using a frequentist random-effects network meta-analysis. Subgroup analyses assessed clinical presentation and guidance objectives such as decision making and procedural optimization.

resultsWe identified 43 randomized controlled trials involving 39 291 patients. IVUS-guided PCI (HR, 0.69 [95% CI, 0.60-0.79]), optical coherence tomography/optical frequency domain imaging-guided PCI (HR, 0.75 [95% CI, 0.63-0.90]), and fractional flow reserve-guided PCI (HR, 0.81 [95% CI, 0.70-0.95]) were associated with a lower risk of MACEs compared with angiography-guided PCI. Furthermore, IVUS-guided PCI was associated with a lower risk of MACEs compared with instantaneous wave-free ratio-guided PCI (HR, 0.74 [95% CI, 0.55-1.00]). IVUS-guided PCI reduced the risk of MACE in both acute coronary syndrome and non-acute coronary syndrome patients.

conclusionsIVUS- and optical coherence tomography/optical frequency domain imaging-guided PCI were superior to angiography-guided PCI in reducing MACEs. Among the physiology-based approaches, only fractional flow reserve showed a clear benefit.

Indexed as

Coronary AngiographyCoronary Artery DiseasePercutaneous Coronary InterventionUltrasonography, InterventionalFractional Flow Reserve, MyocardialHumansPredictive Value of TestsRandomized Controlled Trials as TopicTomography, Optical CoherenceTreatment Outcomefractional flow reserveinstantaneous wave‐free ratiointravascular ultrasoundoptical coherence tomographypercutaneous coronary intervention

Identifiers

PMID41904803
PMCPMC13279237

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.